Xue S, Chen S, Ge Y, Guan T, Han Y
Retrieved from Yin, W
Stahl quote: "Follow the FDA label and never get anybody better" [22:10] When GLP-1s aren't appropriate [24:01] Case study: patient on paliperidone gaining weight despite tirzepatide [25:52] Discovery of nucleus tractus solitaris [28:26] The "are we allowed to prescribe this?" debate [29:10] Valproic acid, propranolol, and scope of practice [30:01] Bipolar disorder, obesity, and mood episode frequency [30:49] Moving beyond the monoamine hypothesis [31:19] UK paper: no proof depression is serotonin deficiency [33:23] Alternative treatments: TMS, ketamine, GLP-1s [34:03] Dr
On top of all that, there's a legal wrinkle around the word "semaglutide" itself that most marketers never mention
For the particular case of guayusa, there are reports of a positive correlation between polyphenolcarotenoid content and antioxidant capacity [18,31], as well as for other species that express a positive relationship between TPC and DPPH parameters, so further studies are required to determine whether the high antioxidant capacity is due to the concentration of phenols, carotenoids, specific compounds, or another particularity [17,70,71]
